New finding may help in dengue fever fight
May 7th, 2010 - 2:02 pm ICT by ANIWashington, May 7 (ANI): A new study by scientists from Imperial College London has found that some of the human immune system’s defences against the virus that causes dengue fever actually help the virus to infect more cells.
According to the researchers, their new findings could help with the design of a vaccine against the dengue virus.
The study also brings scientists closer to understanding why people who contract dengue fever more than once usually experience more severe and dangerous symptoms the second time around.
Dengue fever is transmitted by a mosquito bite and is prevalent in sub-tropical and tropical regions including South East Asia and South America. Symptoms include high fever, severe aching in the joints and vomiting. The dengue virus can also cause hemorrhagic fever, which can be fatal.
Professor Gavin Screaton, the lead author of the study from Imperial College London, and his colleagues identified a set of antibodies, produced by the human immune system to fight off the dengue virus, that they believe scientists should avoid including in any new vaccine to prevent dengue fever.
The new research shows that these precursor membrane protein (prM) antibodies do not do a very effective job of neutralising the virus. Moreover, these antibodies actually help the virus to infect more cells.
The study suggests that when a person who has already been infected with one strain of dengue virus encounters a different strain of dengue virus, the prM antibodies awakened during the first infection spring into action again. However, rather than protecting the body from the second infection, these prM antibodies help the virus to establish itself.
This activity of the prM antibodies could explain why a second infection with a different strain of the virus can cause more harm than the first infection. The researchers believe that if a dengue virus vaccine contained prM antibodies, this could cause similar problems.
The researchers reached their conclusions after analysing individual antibodies to the dengue virus extracted from blood samples donated by infected volunteers.
The new research has been published in the journal Science. (ANI)
- Promising target for AIDS vaccine identified - Apr 01, 2011
- Breast milk antibodies help neutralize HIV - May 23, 2012
- Tweaking antibody could lead to vaccine against HIV - May 08, 2011
- Scientists close to finding meningococcal B shot - May 08, 2012
- New approach to fight HIV could spur vaccine development - Sep 28, 2010
- H1N1 pandemic flu strain 'key to universal vaccine' - Jan 11, 2011
- Hypothesis on mystery of dengue virus infection confirmed - Feb 12, 2010
- Vaccine against four dengue strains to go on trial - Sep 26, 2010
- Can GM mosquitoes wipe out dengue? - Oct 24, 2010
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- Discovery enables quicker diagnosis of chikunguyna - Mar 15, 2012
- FACTSHEETS - Smallpox: in detail - Mar 25, 2010
- Humanized mice paves way for better typhoid fever treatment - Sep 23, 2010
- Antibodies that prevent HIV from infecting human cells found - Jul 09, 2010
- Now, a universal vaccine that kills all strains of flu virus - Feb 07, 2011
Tags: antibodies, cells, dangerous symptoms, defences, dengue virus, high fever, human immune system, imperial college london, joints, membrane protein, mosquito, mosquito bite, precursor, prm, second time, south east asia, spring into action, study suggests that, tropical regions, virus vaccine